Daraxonrasib Approved for Metastatic Pancreatic Cancer
Key Points FDA approved daraxonrasib (RASONQUE) on August 26, 2026, for adults with metastatic pancreatic adenocarcinoma after at least one
Read MoreKey Points FDA approved daraxonrasib (RASONQUE) on August 26, 2026, for adults with metastatic pancreatic adenocarcinoma after at least one
Read MoreKey Points AI analysis identified Pbx1 as a potential regulator of hematopoietic stem cell aging. Aged blood stem cells showed
Read MoreKey Takeaways Autophagy modulation is emerging as a promising strategy to overcome cisplatin-resistant gastric cancer. Researchers identified several existing drugs
Read MoreKey Summary Inherited genetics directly influences cancer susceptibility and the way tumors develop after DNA damage, according to a new
Read MoreKey Takeaways Researchers identified how obesity actively promotes leukemia progression through chronic inflammation. High IL-17A levels and reduced GLP-1 signaling
Read MoreKey Points A large meta-analysis of 28 cohort studies found a small but statistically significant association between allergic diseases and
Read MoreKey Points Summary HPV vaccination is associated with a dramatic reduction in cervical cancer deaths among young women in England.
Read MoreKey Summary A Europe-wide study found that Li-Fraumeni syndrome (LFS) prevention and surveillance programs cost nearly nine times less than
Read MoreKey Takeaways Researchers at the Garvan Institute of Medical Research captured immune macrophages attacking live melanoma cells for the first
Read MoreKey Highlights Researchers at The University of Texas MD Anderson Cancer Center identified macrophage subtypes linked to chemotherapy response in
Read More